Our Identity
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as contrast agents for cancer diagnostics, and theranostics.
Ingenious Platform with PEGylated Bilirubin
BRIXELLE Platform is based on a proprietary technology and can be used to cure many intractable inflammatory diseases. It also can be developed into a highly potent and less toxic anti-cancer drug delivery system and other theranostics applications.
-
arrow_forward
BRIXELLE-INFLA
-
arrow_forward
BRIXELLE-ONCO
-
arrow_forward
BRIXELLE-SHINE
2020-05-21
